Showing results (41-50 of 86) with videos related to
Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Synthesis and SAR of novel conformationally restricted oxazolidinones possessing gram-positive and fastidious gram-negative antibacterial activity. Part 2: Amino substitutions on heterocyclic D-ring systemAllison L Choy, J V N Vara Prasad, Frederick E Boyer, et al.The Journal of Antibiotics|January 23, 2023
Impact of surfactants and other body fluids on in vitro activity of a novel β-lactamase inhibitor enmetazobactam in combination with cefepime against clinical isolates of Klebsiella pneumoniaeAlina Nussbaumer-Pröll, Sabine Eberl, Adam Belley, et al.Journal of Global Antimicrobial Resistance|March 4, 2021
In vitro activity of iclaprim and comparator agents against Listeria monocytogenes clinical isolates from 2012 to 2018David B Huang, Leonard R Duncan, Yahse K Edah, et al.Journal of Global Antimicrobial Resistance|May 5, 2025
In vitro activity of omadacycline against bacterial isolates from bone/joint infections and rare pathogens in the SENTRY antimicrobial surveillance program (2015-2023)Michael D Huband, Paul R Rhomberg, Kelley A Fedler, et al.Jac-Antimicrobial Resistance|December 17, 2021
In vitro activity of a novel aminomethylcycline antibacterial (KBP-7072), a third-generation tetracycline, against clinical isolates with molecularly characterized tetracycline resistance mechanismsMichael A Pfaller, Li Li, Qingmei Liu, et al.Journal of Clinical Microbiology|June 7, 2019
Development of Broth Microdilution MIC and Disk Diffusion Antimicrobial Susceptibility Test Quality Control Ranges for the Combination of Cefepime and the Novel β-Lactamase Inhibitor EnmetazobactamAdam Belley, Michael D Huband, Kelley A Fedler, et al.Journal of Clinical Microbiology|December 14, 2023
Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion testsSarah M McLeod, Nicole M Carter, Michael D Huband, et al.Jac-Antimicrobial Resistance|October 21, 2021
Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from respiratory samples of patients hospitalized with pneumonia in Western Europe, Eastern Europe and the USA: results from the SENTRY Antimicrobial Surveillance Program (2016-19)Helio S Sader, Jennifer M Streit, Cecilia G Carvalhaes, et al.Journal of Clinical Microbiology|December 20, 2024
Use of voriconazole to predict susceptibility and resistance to isavuconazole for Aspergillus fumigatus using CLSI methods and interpretive criteriaMarisa L Winkler, Paul R Rhomberg, Kelley A Fedler, et al.Diagnostic Microbiology and Infectious Disease|February 1, 2025
Surveillance of omadacycline against 35,000 bacterial clinical isolates from the United States (2019-2023)Michael D Huband, Kelley A Fedler, Rodrigo E Mendes, et al.Pageof 9